atDose
atDose Co., Ltd. is focused on developing a new drug delivery platform utilizing their core technology, the Electro-Osmotic Pump (EO pump). Their mission is to enable ultra-small, continuous local drug delivery, with applications in ophthalmology, cancer treatment, and research. They aim to revolutionize healthcare by providing precise, localized drug administration and are actively seeking research partners and collaborations with medical device manufacturers.
Industries
Nr. of Employees
small (1-50)
Products
Electro-osmotic pump-based dosing device
A miniaturized dosing device using electro-osmotic pumping to provide continuous, localized micro-dosing with precise control over timing, quantity, and flow rate; designed to operate with thin-needle minimally invasive delivery and capable of handling viscous therapeutic fluids.
Electro-osmotic pump-based dosing device
A miniaturized dosing device using electro-osmotic pumping to provide continuous, localized micro-dosing with precise control over timing, quantity, and flow rate; designed to operate with thin-needle minimally invasive delivery and capable of handling viscous therapeutic fluids.
Services
Custom device development and research collaboration
Collaborative R&D and custom development of dosing devices and integrations for localized, continuous drug administration tailored to research or clinical applications.
Custom device development and research collaboration
Collaborative R&D and custom development of dosing devices and integrations for localized, continuous drug administration tailored to research or clinical applications.
Expertise Areas
- Continuous localized drug delivery
- Micro-pump engineering
- Localized micro-dosing for in vivo and in vitro research
- Ophthalmic applications for minimally invasive surgery
Key Technologies
- Electro-osmotic pumping
- Microfluidic control
- Precision micro-dosing
- Viscous fluid handling